Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cAMP-specific 3',5'-cyclic phosphodiesterase 4A (Cavia porcellus) | BDBM15296![]() (6-methyl-2-oxo-5-(pyridin-4-yl)-1,2-dihydropyridin...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar | Purchase CHEBI CHEMBL DrugBank KEGG MMDB PC cid PC sid PDB UniChem Patents Similars | 4.67E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Assay Description Inhibition of Cavia porcellus (guinea pig) PDE3 isolated from heart using [3H]cAMP as substrate by two-step method | Citation and Details BindingDB Entry DOI: 10.7270/Q2PV6P8K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 4 (Homo sapiens (Human)) | BDBM285634![]() (3-(4-chloro-3,5-difluoro-phenyl)-N-cyclopropyl-imi...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.488 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10077269 (2018) BindingDB Entry DOI: 10.7270/Q2P84DX5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 4 (Homo sapiens (Human)) | BDBM285598![]() (3-(3-chloro-4-methylphenyl)-N-[(1R,2S)-2-fluorocyc...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.669 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10077269 (2018) BindingDB Entry DOI: 10.7270/Q2P84DX5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 3 (Homo sapiens (Human)) | BDBM399979![]() (US10323042, Example 58) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 4 (Homo sapiens (Human)) | BDBM285537![]() (3-(4-chloro-3-fluoro-phenyl)-N-cyclopropyl-imidazo...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.51 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10077269 (2018) BindingDB Entry DOI: 10.7270/Q2P84DX5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 3 (Homo sapiens (Human)) | BDBM399978![]() (US10323042, Example 57) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.86 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 3 (Homo sapiens (Human)) | BDBM399927![]() ((6S)-3-(4-Chloro-2,5-difluorophenyl)-N-cyclopropyl...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 4 (Homo sapiens (Human)) | BDBM285534![]() (3-(4-Chloro-3-fluorophenyl)-N-(1-methyl-1H-pyrazol...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.77 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10077269 (2018) BindingDB Entry DOI: 10.7270/Q2P84DX5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 4 (Homo sapiens (Human)) | BDBM285572![]() (3-(4-chloro-3-fluorophenyl)-N-[(1R,2S)-2-fluorocyc...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.91 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10077269 (2018) BindingDB Entry DOI: 10.7270/Q2P84DX5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 4 (Homo sapiens (Human)) | BDBM285568![]() (N-cyclopropyl-3-(3-fluoro-4-methylphenyl)imidazo[1...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.13 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10077269 (2018) BindingDB Entry DOI: 10.7270/Q2P84DX5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 4 (Homo sapiens (Human)) | BDBM285556![]() (3-(4-chloro-3-fluorophenyl)-N-propylimidazo[1,2-b]...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.48 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10077269 (2018) BindingDB Entry DOI: 10.7270/Q2P84DX5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 4 (Homo sapiens (Human)) | BDBM285536![]() (3-(4-Chloro-2,5-difluorophenyl)-N-cyclopropylimida...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.83 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10077269 (2018) BindingDB Entry DOI: 10.7270/Q2P84DX5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 4 (Homo sapiens (Human)) | BDBM285576![]() (US10077269, Example 49 | US9598421, Example 49 | a...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.16 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10077269 (2018) BindingDB Entry DOI: 10.7270/Q2P84DX5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 4 (Homo sapiens (Human)) | BDBM285626![]() (3-(4-chloro-2,5-difluoro-phenyl)-N-ethylimidazo[1,...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.58 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10077269 (2018) BindingDB Entry DOI: 10.7270/Q2P84DX5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 4 (Homo sapiens (Human)) | BDBM285551![]() (4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazi...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.04 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10077269 (2018) BindingDB Entry DOI: 10.7270/Q2P84DX5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 4 (Homo sapiens (Human)) | BDBM285540![]() (US10077269, Example 13 | US9598421, Example 13 | a...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.13 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10077269 (2018) BindingDB Entry DOI: 10.7270/Q2P84DX5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 3 (Homo sapiens (Human)) | BDBM399928![]() (3-(4-Chloro-2-methylphenyl)-N-cyclopropyl-6,6-difl...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.29 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 3 (Homo sapiens (Human)) | BDBM399973![]() (US10323042, Example 53A | US10323042, Example 53B) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.35 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 4 (Homo sapiens (Human)) | BDBM285627![]() (3-(4-chloro-5-fluoro-2-methylphenyl)-N-(propan-2-y...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.48 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10077269 (2018) BindingDB Entry DOI: 10.7270/Q2P84DX5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 4 (Homo sapiens (Human)) | BDBM285622![]() (3-(4-cyano-2,5-difluorophenyl)-N-cyclopropylimidaz...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.52 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10077269 (2018) BindingDB Entry DOI: 10.7270/Q2P84DX5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 4 (Homo sapiens (Human)) | BDBM285616![]() (US10077269, Example 86 | US9598421, Example 86 | a...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.83 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10077269 (2018) BindingDB Entry DOI: 10.7270/Q2P84DX5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 4 (Homo sapiens (Human)) | BDBM285613![]() (US10077269, Example 83 | US9598421, Example 83 | a...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.21 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10077269 (2018) BindingDB Entry DOI: 10.7270/Q2P84DX5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 3 (Homo sapiens (Human)) | BDBM399973![]() (US10323042, Example 53A | US10323042, Example 53B) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.45 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 4 (Homo sapiens (Human)) | BDBM285547![]() (4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazi...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.70 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10077269 (2018) BindingDB Entry DOI: 10.7270/Q2P84DX5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 4 (Homo sapiens (Human)) | BDBM285603![]() (US10077269, Example 76 | US9598421, Example 76 | a...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.09 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10077269 (2018) BindingDB Entry DOI: 10.7270/Q2P84DX5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 4 (Homo sapiens (Human)) | BDBM285574![]() (US10077269, Example 47 | US9598421, Example 47 | a...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.37 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10077269 (2018) BindingDB Entry DOI: 10.7270/Q2P84DX5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 4 (Homo sapiens (Human)) | BDBM285611![]() (3-(4-chloro-3-fluorophenyl)-N-ethylimidazo[1,2-b]p...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.86 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10077269 (2018) BindingDB Entry DOI: 10.7270/Q2P84DX5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 4 (Homo sapiens (Human)) | BDBM285602![]() (N-cyclopropyl-3-[2-(difluoro-methoxy)pyridin-4-yl]...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 10.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10077269 (2018) BindingDB Entry DOI: 10.7270/Q2P84DX5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 4 (Homo sapiens (Human)) | BDBM285595![]() (3-(4-chloro-2-fluorophenyl)-N-[(1R,2S)-2-fluorocyc...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 10.6 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10077269 (2018) BindingDB Entry DOI: 10.7270/Q2P84DX5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 4 (Homo sapiens (Human)) | BDBM285529![]() (3-(4-Chlorophenyl)-N-cyclopropylimidazo[1,2-b]pyri...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 10.7 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10077269 (2018) BindingDB Entry DOI: 10.7270/Q2P84DX5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 3 (Homo sapiens (Human)) | BDBM399937![]() (US10323042, Example 17) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 4 (Homo sapiens (Human)) | BDBM285557![]() (3-(4-chlorophenyl)-N-(2-methylcyclopropyl)imidazo[...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 11.6 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10077269 (2018) BindingDB Entry DOI: 10.7270/Q2P84DX5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 4 (Homo sapiens (Human)) | BDBM285612![]() (3-(4-chloro-3-fluorophenyl)-N-(1H-pyrazol-4-yl)imi...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 12 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10077269 (2018) BindingDB Entry DOI: 10.7270/Q2P84DX5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 3 (Homo sapiens (Human)) | BDBM399971![]() (US10323042, Example 51) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 12 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 3 (Homo sapiens (Human)) | BDBM399968![]() (US10323042, Example 48) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 12.1 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 4 (Homo sapiens (Human)) | BDBM285621![]() (US10077269, Example 91 | US9598421, Example 91 | a...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 12.6 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10077269 (2018) BindingDB Entry DOI: 10.7270/Q2P84DX5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 4 (Homo sapiens (Human)) | BDBM285530![]() (Azetidin-1-yl[3-(3,5-difluoro-4-methoxyphenyl)imid...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 12.7 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10077269 (2018) BindingDB Entry DOI: 10.7270/Q2P84DX5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 3 (Homo sapiens (Human)) | BDBM399969![]() (US10323042, Example 49) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 13.3 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 4 (Homo sapiens (Human)) | BDBM285539![]() (3-(4-chloro-2-methyl-phenyl)-N-cyclopropyl-imidazo...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 14.4 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10077269 (2018) BindingDB Entry DOI: 10.7270/Q2P84DX5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 3 (Homo sapiens (Human)) | BDBM399926![]() ((6S)-3-(4-Chloro-2-methylphenyl)-N-cyclopropyl-6-f...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 14.4 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 4 (Homo sapiens (Human)) | BDBM285566![]() (3-(1,3-benzoxazol-5-yl)-N-cyclopropylimidazo[1,2-b...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 14.8 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10077269 (2018) BindingDB Entry DOI: 10.7270/Q2P84DX5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 4 (Homo sapiens (Human)) | BDBM285550![]() (4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazi...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 15.1 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10077269 (2018) BindingDB Entry DOI: 10.7270/Q2P84DX5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 4 (Homo sapiens (Human)) | BDBM285573![]() (3-(4-chlorophenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 15.2 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10077269 (2018) BindingDB Entry DOI: 10.7270/Q2P84DX5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 4 (Homo sapiens (Human)) | BDBM285555![]() (3-(3,5-dichlorophenyl)-N-propylimidazo[1,2-b]pyrid...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 15.6 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10077269 (2018) BindingDB Entry DOI: 10.7270/Q2P84DX5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 3 (Homo sapiens (Human)) | BDBM399967![]() (US10323042, Example 47) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 15.7 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 4 (Homo sapiens (Human)) | BDBM285614![]() (US10077269, Example 84 | US9598421, Example 84 | a...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 16.7 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10077269 (2018) BindingDB Entry DOI: 10.7270/Q2P84DX5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 4 (Homo sapiens (Human)) | BDBM285546![]() (3-(4-cyano-5-fluoro-2-methylphenyl)-N-cyclo-propyl...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 16.9 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10077269 (2018) BindingDB Entry DOI: 10.7270/Q2P84DX5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 4 (Homo sapiens (Human)) | BDBM285580![]() (US10077269, Example 53 | US9598421, Example 53 | a...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 17.8 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10077269 (2018) BindingDB Entry DOI: 10.7270/Q2P84DX5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 4 (Homo sapiens (Human)) | BDBM285567![]() (3-(4-chloro-2-fluorophenyl)-N-cyclopropylimidazo[1...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 19.6 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10077269 (2018) BindingDB Entry DOI: 10.7270/Q2P84DX5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 3 (Homo sapiens (Human)) | BDBM399960![]() (US10323042, Example 40) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 19.7 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc US Patent | Assay Description The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD... | US Patent US10323042 (2019) BindingDB Entry DOI: 10.7270/Q2NP26RH | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 141 total ) | Next | Last >> |